Sastasundar Ven.
NSE: SASTASUNDR · Pharmacy Retail
Snapshot
Unlock Sastasundar Ven.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Sastasundar Ventures Limited operates as a diversified entity with interests in digital healthcare and financial services. Its healthcare operations include online pharmacy portals, diagnostic services, and health consultancy, while its financial arm provides investment, wealth management, and consultancy services.
Business Model
The company generates revenue through the digital distribution of medicines and wellness products, diagnostic testing services, and the provision of financial consultancy and wealth management fees.
Growth Outlook
Growth is driven by the expansion of its digital healthcare platforms, sastasundar.com and retailershakti.com, alongside its established financial services portfolio.
Key Risks
- Regulatory Risk. The company faces stringent and evolving regulations governing the online pharmacy and diagnostic sectors in India.
- Market Competition. Intense competition from well-funded e-pharmacy players and traditional retail chains may impact market share and margins.
- Financial Market Volatility. The company's investment and wealth management business is susceptible to fluctuations in the Indian equity and debt markets.
- Operational Risk. Maintaining a complex digital supply chain for healthcare products and diagnostic services requires significant logistical efficiency and technology investment.
Price
Start your research today
Unlock AI insights, financials, peers and live data on Sastasundar Ven. and 5,000+ companies — free.
Key Metrics
REVENUE
₹1,319 Cr
TTM · consolidated
NET PROFIT
₹-1 Cr
TTM · consolidated
EPS
₹0.37
TTM · consolidated
RETURN ON EQUITY
-0.2%
TTM · consolidated
P/E
763.8x
Q4 FY26 · consolidated
EBITDA MARGIN
0.5%
TTM · consolidated
NET PROFIT MARGIN
-3.5%
Q4 FY26 · consolidated
Peers · Pharmacy Retail
| Company | Mkt Cap (Cr) | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Sastasundar Ven.SASTASUNDR | 890 | 763.78 | — | 18.8% | 0.5% | -0.2% | -24.3% | — |
MedPlus Health Services LimitedMEDPLUS | 10,004 | 44.16 | 14.02 | 12.3% | 9.8% | 12.2% | 13.7% | -12.7% |
Entero Healthcare Solutions LimitedENTERO | 5,289 | 45.59 | 19.87 | 29.3% | 4.3% | 8.5% | 2.0% | +0.9% |
As of Q4 FY26
Financials
Sastasundar Ven.
NSE: SASTASUNDR · Pharmacy Retail
Snapshot
Unlock Sastasundar Ven.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Sastasundar Ventures Limited operates as a diversified entity with interests in digital healthcare and financial services. Its healthcare operations include online pharmacy portals, diagnostic services, and health consultancy, while its financial arm provides investment, wealth management, and consultancy services.
Business Model
The company generates revenue through the digital distribution of medicines and wellness products, diagnostic testing services, and the provision of financial consultancy and wealth management fees.
Growth Outlook
Growth is driven by the expansion of its digital healthcare platforms, sastasundar.com and retailershakti.com, alongside its established financial services portfolio.
Key Risks
- Regulatory Risk. The company faces stringent and evolving regulations governing the online pharmacy and diagnostic sectors in India.
- Market Competition. Intense competition from well-funded e-pharmacy players and traditional retail chains may impact market share and margins.
- Financial Market Volatility. The company's investment and wealth management business is susceptible to fluctuations in the Indian equity and debt markets.
- Operational Risk. Maintaining a complex digital supply chain for healthcare products and diagnostic services requires significant logistical efficiency and technology investment.
Price
Loading…
Start your research today
Unlock AI insights, financials, peers and live data on Sastasundar Ven. and 5,000+ companies — free.
Key Metrics
REVENUE
₹1,319 Cr
TTM · consolidated
NET PROFIT
₹-1 Cr
TTM · consolidated
EPS
₹0.37
TTM · consolidated
RETURN ON EQUITY
-0.2%
TTM · consolidated
P/E
763.8x
Q4 FY26 · consolidated
EBITDA MARGIN
0.5%
TTM · consolidated
NET PROFIT MARGIN
-3.5%
Q4 FY26 · consolidated
Peers · Pharmacy Retail
As of Q4 FY26